{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T14:14:20Z","timestamp":1769350460993,"version":"3.49.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T00:00:00Z","timestamp":1331683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00213-012-2671-7","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T18:10:07Z","timestamp":1331662207000},"page":"663-674","source":"Crossref","is-referenced-by-count":35,"title":["Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain"],"prefix":"10.1007","volume":"222","author":[{"given":"Hyung-Wook","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yewon","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiren R.","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley I.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadeesh S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"issue":"2","key":"2671_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","volume":"9","author":"RJ Baldessarini","year":"1993","unstructured":"Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9(2):117\u2013124","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"2671_CR2","first-page":"295","volume":"55","author":"MD Banov","year":"1994","unstructured":"Banov MD, Zarate CA Jr, Tohen M, Scialabba D, Wines JD Jr, Kolbrener M et al (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 55(7):295\u2013300","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2671_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0091-3057(93)90084-7","volume":"45","author":"T Baptista","year":"1993","unstructured":"Baptista T, Mata A, Teneud L, de Quijada M, Han HW, Hernandez L (1993) Effects of long-term administration of clozapine on body weight and food intake in rats. Pharmacol Biochem Behav 45(1):51\u201354","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"2671_CR4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.npp.1300671","volume":"30","author":"M Basselin","year":"2005","unstructured":"Basselin M, Chang L, Bell JM, Rapoport SI (2005) Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacology 30(6):1064\u20131075","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"2671_CR5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.npp.1300920","volume":"31","author":"M Basselin","year":"2006","unstructured":"Basselin M, Chang L, Bell JM, Rapoport SI (2006) Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31(8):1659\u20131674","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"2671_CR6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2007.04.021","volume":"62","author":"M Basselin","year":"2007","unstructured":"Basselin M, Villacreses NE, Chen M, Bell JM, Rapoport SI (2007a) Chronic carbamazepine administration reduces N-methyl-d-aspartate receptor-initiated signaling via arachidonic acid in rat brain. Biol Psychiatry 62(8):934\u2013943","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2671_CR7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1471-4159.2007.04593.x","volume":"102","author":"M Basselin","year":"2007","unstructured":"Basselin M, Villacreses NE, Lee HJ, Bell JM, Rapoport SI (2007b) Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem 102(3):761\u2013772","journal-title":"J Neurochem"},{"issue":"7","key":"2671_CR8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11064-008-9595-y","volume":"33","author":"M Basselin","year":"2008","unstructured":"Basselin M, Chang L, Chen M, Bell JM, Rapoport SI (2008) Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain. Neurochem Res 33(7):1373\u20131383","journal-title":"Neurochem Res"},{"issue":"2","key":"2671_CR9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MCO.0b013e32802b7030","volume":"10","author":"NG Bazan","year":"2007","unstructured":"Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10(2):136\u2013141","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"2671_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00213-005-0059-7","volume":"182","author":"RP Bazinet","year":"2005","unstructured":"Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ (2005) Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Psychopharmacology (Berl) 182(1):180\u2013185","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"2671_CR11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.neuroimage.2007.06.012","volume":"37","author":"AK Bhattacharjee","year":"2007","unstructured":"Bhattacharjee AK, Meister LM, Chang L, Bazinet RP, White L, Rapoport SI (2007) In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease. NeuroImage 37(4):1112\u20131121","journal-title":"NeuroImage"},{"issue":"4","key":"2671_CR12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00213-008-1073-3","volume":"197","author":"AK Bhattacharjee","year":"2008","unstructured":"Bhattacharjee AK, Chang L, White L, Bazinet RP, Rapoport SI (2008) Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats. Psychopharmacology (Berl) 197(4):557\u2013566","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"2671_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2006.04030.x","volume":"99","author":"L Bragina","year":"2006","unstructured":"Bragina L, Melone M, Fattorini G, Torres-Ramos M, Vallejo-Illarramendi A, Matute C et al (2006) GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation. J Neurochem 99(1):134\u2013141","journal-title":"J Neurochem"},{"issue":"6","key":"2671_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.153.6.759","volume":"153","author":"JR Calabrese","year":"1996","unstructured":"Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA et al (1996) Clozapine for treatment-refractory mania. Am J Psychiatry 153(6):759\u2013764","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2671_CR15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","volume":"43","author":"F Calon","year":"2004","unstructured":"Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O et al (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43(5):633\u2013645","journal-title":"Neuron"},{"issue":"3","key":"2671_CR16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11064-008-9817-3","volume":"34","author":"YC Chang","year":"2009","unstructured":"Chang YC, Rapoport SI, Rao JS (2009) Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem Res 34(3):536\u2013541","journal-title":"Neurochem Res"},{"issue":"19","key":"2671_CR17","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.lfs.2004.12.004","volume":"76","author":"CY Cheng","year":"2005","unstructured":"Cheng CY, Hong CJ, Tsai SJ (2005) Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB\/c mice. Life Sci 76(19):2269\u20132273","journal-title":"Life Sci"},{"issue":"2","key":"2671_CR18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1471-4159.2011.07410.x","volume":"119","author":"Y Cheon","year":"2011","unstructured":"Cheon Y, Park JY, Modi HR, Kim HW, Lee HJ, Chang L et al (2011) Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E concentration in rat brain. J Neurochem 119(2):364\u2013376","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"2671_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2005.09.005","volume":"26","author":"GM Cole","year":"2005","unstructured":"Cole GM, Lim GP, Yang F, Teter B, Begum A, Ma Q et al (2005) Prevention of Alzheimer's disease: omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol Aging 26(Suppl 1):133\u2013136","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2671_CR20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pnpbp.2007.09.012","volume":"32","author":"GD Cooper","year":"2008","unstructured":"Cooper GD, Harrold JA, Halford JC, Goudie AJ (2008) Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 32(2):428\u2013436","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"2671_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jnr.490240311","volume":"24","author":"JJ DeGeorge","year":"1989","unstructured":"DeGeorge JJ, Noronha JG, Bell J, Robinson P, Rapoport SI (1989) Intravenous injection of [1-14\u00a0C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J Neurosci Res 24(3):413\u2013423","journal-title":"J Neurosci Res"},{"issue":"1","key":"2671_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1194\/jlr.M500362-JLR200","volume":"47","author":"JC DeMar Jr","year":"2006","unstructured":"DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI (2006) One generation of n\u2009\u2212\u20093 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 47(1):172\u2013180","journal-title":"J Lipid Res"},{"issue":"5","key":"2671_CR23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0361-9230(01)00530-5","volume":"55","author":"SL Eastwood","year":"2001","unstructured":"Eastwood SL, Harrison PJ (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55(5):569\u2013578","journal-title":"Brain Res Bull"},{"issue":"2","key":"2671_CR24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0306-4522(94)00586-T","volume":"66","author":"SL Eastwood","year":"1995","unstructured":"Eastwood SL, Burnet PW, Harrison PJ (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66(2):309\u2013319","journal-title":"Neuroscience"},{"issue":"1","key":"2671_CR25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0306-4522(01)00141-5","volume":"105","author":"SL Eastwood","year":"2001","unstructured":"Eastwood SL, Cotter D, Harrison PJ (2001) Cerebellar synaptic protein expression in schizophrenia. Neuroscience 105(1):219\u2013229","journal-title":"Neuroscience"},{"key":"2671_CR26","doi-asserted-by":"crossref","unstructured":"Farde L, Nordstrom AL (1992a) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry Suppl(17): 30-33","DOI":"10.1192\/S0007125000296888"},{"issue":"5","key":"2671_CR27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/jcbfm.1989.98","volume":"9","author":"L Farde","year":"1989","unstructured":"Farde L, Eriksson L, Blomquist G, Halldin C (1989) Kinetic analysis of central [11 C]raclopride binding to D2-dopamine receptors studied by PET\u2014a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9(5):696\u2013708","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"2671_CR28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"L Farde","year":"1992","unstructured":"Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49(7):538\u2013544","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"2671_CR29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4088\/JCP.v67n1217","volume":"67","author":"MP Freeman","year":"2006","unstructured":"Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M et al (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67(12):1954\u20131967","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"2671_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0006-8993(97)00583-0","volume":"768","author":"MC Garcia","year":"1997","unstructured":"Garcia MC, Kim HY (1997) Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells. Brain Res 768(1\u20132):43\u201348","journal-title":"Brain Res"},{"issue":"4","key":"2671_CR31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biopsych.2004.05.012","volume":"56","author":"S Ghelardoni","year":"2004","unstructured":"Ghelardoni S, Tomita YA, Bell JM, Rapoport SI, Bosetti F (2004) Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol Psychiatry 56(4):248\u2013254","journal-title":"Biol Psychiatry"},{"issue":"6","key":"2671_CR32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/appi.ajp.157.6.982","volume":"157","author":"AI Green","year":"2000","unstructured":"Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I et al (2000) Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 157(6):982\u2013986","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"2671_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","volume":"41","author":"RW Grillo","year":"2007","unstructured":"Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR (2007) Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res 41(1\u20132):31\u201335","journal-title":"J Psychiatr Res"},{"issue":"6","key":"2671_CR34","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.npp.1300422","volume":"29","author":"ND Halim","year":"2004","unstructured":"Halim ND, Weickert CS, McClintock BW, Weinberger DR, Lipska BK (2004) Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29(6):1063\u20131069","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 23","key":"2671_CR35","first-page":"39","volume":"62","author":"DC Henderson","year":"2001","unstructured":"Henderson DC (2001) Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. J Clin Psychiatry 62(Suppl 23):39\u201344","journal-title":"J Clin Psychiatry"},{"key":"2671_CR36","doi-asserted-by":"crossref","unstructured":"Igarashi M, Kim HW, Chang L, Ma K, Rapoport SI (2011) Dietary N\u2009\u2212\u20096 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain. J Neurochem","DOI":"10.1111\/j.1471-4159.2011.07597.x"},{"issue":"5","key":"2671_CR37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2044.2000.01271.x","volume":"55","author":"PC Kam","year":"2000","unstructured":"Kam PC, See AU (2000) Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55(5):442\u2013449","journal-title":"Anaesthesia"},{"issue":"2","key":"2671_CR38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","volume":"156","author":"S Kapur","year":"1999","unstructured":"Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156(2):286\u2013293","journal-title":"Am J Psychiatry"},{"key":"2671_CR39","doi-asserted-by":"crossref","unstructured":"Kim HW, Rapoport SI, Rao JS (2010) Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 37(3):596\u2013603","DOI":"10.1016\/j.nbd.2009.11.010"},{"issue":"4","key":"2671_CR40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/mp.2009.137","volume":"16","author":"HW Kim","year":"2011","unstructured":"Kim HW, Rapoport SI, Rao JS (2011) Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol Psychiatry 16(4):419\u2013428","journal-title":"Mol Psychiatry"},{"issue":"3","key":"2671_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jnr.20092","volume":"76","author":"AJ Law","year":"2004","unstructured":"Law AJ, Hutchinson LJ, Burnet PW, Harrison PJ (2004) Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex. J Neurosci Res 76(3):376\u2013382","journal-title":"J Neurosci Res"},{"issue":"1","key":"2671_CR42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1194\/jlr.M700406-JLR200","volume":"49","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP (2008) Chronic N-methyl-d-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J Lipid Res 49(1):162\u2013168","journal-title":"J Lipid Res"},{"issue":"5","key":"2671_CR43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3171\/jns.1985.63.5.0659","volume":"63","author":"JB Leslie","year":"1985","unstructured":"Leslie JB, Watkins WD (1985) Eicosanoids in the central nervous system. J Neurosurg 63(5):659\u2013668","journal-title":"J Neurosurg"},{"issue":"4","key":"2671_CR44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"1\u20134","key":"2671_CR45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.prostaglandins.2005.02.004","volume":"77","author":"KK Lucas","year":"2005","unstructured":"Lucas KK, Dennis EA (2005) Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat 77(1\u20134):235\u2013248","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"10","key":"2671_CR46","first-page":"411","volume":"52","author":"SL McElroy","year":"1991","unstructured":"McElroy SL, Dessain EC, Pope HG Jr, Cole JO, Keck PE Jr, Frankenberg FR et al (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 52(10):411\u2013414","journal-title":"J Clin Psychiatry"},{"key":"2671_CR47","doi-asserted-by":"crossref","unstructured":"Montgomery P, Richardson AJ (2008) Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev(2): CD005169","DOI":"10.1002\/14651858.CD005169.pub2"},{"issue":"3","key":"2671_CR48","first-page":"391","volume":"39","author":"WY Ong","year":"1999","unstructured":"Ong WY, Sandhya TL, Horrocks LA, Farooqui AA (1999) Distribution of cytoplasmic phospholipase A2 in the normal rat brain. J Hirnforsch 39(3):391\u2013400","journal-title":"J Hirnforsch"},{"issue":"1","key":"2671_CR49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","volume":"134","author":"GS Peng","year":"2005","unstructured":"Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD et al (2005) Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Brain Res Mol Brain Res 134(1):162\u2013169","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"2671_CR50","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/jnr.22266","volume":"88","author":"SE Perez","year":"2010","unstructured":"Perez SE, Berg BM, Moore KA, He B, Counts SE, Fritz JJ et al (2010) DHA diet reduces AD pathology in young APPswe\/PS1 Delta E9 transgenic mice: possible gender effects. J Neurosci Res 88(5):1026\u20131040","journal-title":"J Neurosci Res"},{"issue":"7256","key":"2671_CR51","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"SM Purcell","year":"2009","unstructured":"Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256):748\u2013752","journal-title":"Nature"},{"key":"2671_CR52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0076-6879(81)72003-2","volume":"72","author":"NS Radin","year":"1981","unstructured":"Radin NS (1981) Extraction of tissue lipids with a solvent of low toxicity. Methods Enzymol 72:5\u20137","journal-title":"Methods Enzymol"},{"issue":"8","key":"2671_CR53","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1194\/jlr.M006262","volume":"51","author":"E Ramadan","year":"2010","unstructured":"Ramadan E, Rosa AO, Chang L, Chen M, Rapoport SI (2010) Basselin M Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid. J Lipid Res 51(8):2334\u20132340","journal-title":"J Lipid Res"},{"issue":"47","key":"2671_CR54","doi-asserted-by":"crossref","first-page":"13929","DOI":"10.1021\/bi034843p","volume":"42","author":"S Ramanadham","year":"2003","unstructured":"Ramanadham S, Song H, Hsu FF, Zhang S, Crankshaw M, Grant GA et al (2003) Pancreatic islets and insulinoma cells express a novel isoform of group VIA phospholipase A2 (iPLA2 beta) that participates in glucose-stimulated insulin secretion and is not produced by alternate splicing of the iPLA2 beta transcript. Biochemistry 42(47):13929\u201313940","journal-title":"Biochemistry"},{"issue":"5","key":"2671_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1399-5618.2007.00361.x","volume":"9","author":"JS Rao","year":"2007","unstructured":"Rao JS, Bazinet RP, Rapoport SI, Lee HJ (2007a) Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA. Bipolar Disord 9(5):513\u2013520","journal-title":"Bipolar Disord"},{"issue":"2","key":"2671_CR56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.mp.4001887","volume":"12","author":"JS Rao","year":"2007","unstructured":"Rao JS, Ertley RN, DeMar JC Jr, Rapoport SI, Bazinet RP, Lee HJ (2007b) Dietary n\u2009\u2212\u20093 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 12(2):151\u2013157","journal-title":"Mol Psychiatry"},{"issue":"6","key":"2671_CR57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mp.2008.31","volume":"13","author":"JS Rao","year":"2008","unstructured":"Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry 13(6):585\u2013596","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2671_CR58","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","volume":"15","author":"JS Rao","year":"2010","unstructured":"Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15(4):384\u2013392","journal-title":"Mol Psychiatry"},{"issue":"1\u20132","key":"2671_CR59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2011.08.017","volume":"136","author":"JS Rao","year":"2012","unstructured":"Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord 136(1\u20132):63\u201371","journal-title":"J Affect Disord"},{"issue":"2","key":"2671_CR60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","volume":"61","author":"SI Rapoport","year":"2009","unstructured":"Rapoport SI, Basselin M, Kim HW, Rao JS (2009) Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev 61(2):185\u2013209","journal-title":"Brain Res Rev"},{"issue":"18","key":"2671_CR61","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1097\/00001756-199912160-00030","volume":"10","author":"J Rintala","year":"1999","unstructured":"Rintala J, Seemann R, Chandrasekaran K, Rosenberger TA, Chang L, Contreras MA et al (1999) 85\u00a0kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. Neuroreport 10(18):3887\u20133890","journal-title":"Neuroreport"},{"issue":"10","key":"2671_CR62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0024-3205(79)90544-7","volume":"25","author":"C Rolsten","year":"1979","unstructured":"Rolsten C, Claghorn J, Samorajski T (1979) Long-term treatment with clozapine on aging mice. Life Sci 25(10):865\u2013872","journal-title":"Life Sci"},{"issue":"2","key":"2671_CR63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","volume":"631","author":"A Schotte","year":"1993","unstructured":"Schotte A, Janssen PF, Megens AA, Leysen JE (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631(2):191\u2013202","journal-title":"Brain Res"},{"issue":"6","key":"2671_CR64","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.156.6.876","volume":"156","author":"P Seeman","year":"1999","unstructured":"Seeman P, Tallerico T (1999) Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry 156(6):876\u2013884","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2671_CR65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atc.2006.01.003","volume":"24","author":"CN Serhan","year":"2006","unstructured":"Serhan CN (2006) Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin 24(2):341\u2013364","journal-title":"Anesthesiol Clin"},{"key":"2671_CR66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jb\/117.2.231","volume":"117","author":"T Shirao","year":"1995","unstructured":"Shirao T (1995) The role of microfilament-associated proteins, drebrins, in brain morphogenesis: a review. J Biochem (Tokyo) 117:231\u2013236","journal-title":"J Biochem (Tokyo)"},{"issue":"2","key":"2671_CR67","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbr.2010.08.046","volume":"216","author":"M Shobo","year":"2011","unstructured":"Shobo M, Yamada H, Mihara T, Kondo Y, Irie M, Harada K et al (2011) Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone. Behav Brain Res 216(2):561\u2013568","journal-title":"Behav Brain Res"},{"issue":"1\u20132","key":"2671_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","volume":"1488","author":"DA Six","year":"2000","unstructured":"Six DA, Dennis EA (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 1488(1\u20132):1\u201319","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2671_CR69","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/me.2004-0169","volume":"19","author":"K Song","year":"2005","unstructured":"Song K, Zhang X, Zhao C, Ang NT, Ma ZA (2005) Inhibition of Ca2\u2009+\u2009-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance. Mol Endocrinol 19(2):504\u2013515","journal-title":"Mol Endocrinol"},{"issue":"7","key":"2671_CR70","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijdevneu.2004.07.002","volume":"22","author":"M Strokin","year":"2004","unstructured":"Strokin M, Sergeeva M, Reiser G (2004) Role of Ca2\u2009+\u2009-independent phospholipase A2 and n\u2009\u2212\u20093 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int J Dev Neurosci 22(7):551\u2013557","journal-title":"Int J Dev Neurosci"},{"issue":"1\u20133","key":"2671_CR71","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.08.011","volume":"89","author":"EA Thomas","year":"2007","unstructured":"Thomas EA, Yao JK (2007) Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D. Schizophr Res 89(1\u20133):147\u2013153","journal-title":"Schizophr Res"},{"issue":"6","key":"2671_CR72","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1046\/j.1471-4159.1995.64062765.x","volume":"64","author":"D Vial","year":"1995","unstructured":"Vial D, Piomelli D (1995) Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2. J Neurochem 64(6):2765\u20132772","journal-title":"J Neurochem"},{"issue":"8","key":"2671_CR73","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/138945008785132385","volume":"9","author":"WP Wilkins 3rd","year":"2008","unstructured":"Wilkins WP 3rd, Barbour SE (2008) Group VI phospholipases A2: homeostatic phospholipases with significant potential as targets for novel therapeutics. Curr Drug Targets 9(8):683\u2013697","journal-title":"Curr Drug Targets"},{"issue":"2","key":"2671_CR74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/abio.1999.4053","volume":"269","author":"HC Yang","year":"1999","unstructured":"Yang HC, Mosior M, Johnson CA, Chen Y, Dennis EA (1999) Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem 269(2):278\u2013288","journal-title":"Anal Biochem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2671-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2671-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2671-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T11:03:56Z","timestamp":1713697436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2671-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2671"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2671-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,14]]}}}